AeviceMD for Pediatric Asthma Management

Description

A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize treatment for these patients using objective data collected from and of these patients outside of the clinic. The AeviceMD should also be used as a remote auscultation device for teleconsultations.

Conditions

Asthma, Asthma in Children, Pediatric Asthma, Chronic Respiratory Disease

Study Overview

Study Details

Study overview

A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize treatment for these patients using objective data collected from and of these patients outside of the clinic. The AeviceMD should also be used as a remote auscultation device for teleconsultations.

AeviceMD for Pediatric Asthma Management

AeviceMD for Pediatric Asthma Management

Condition
Asthma
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Cedars-Sinai Medical Center, Los Angeles, California, United States, 90048

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision of signed and dated informed consent form
  • * Stated willingness to comply with all study procedures and availability for the duration of the study
  • * Aged 3 to 18 as of first recruitment
  • * Diagnosed with poorly controlled asthma
  • * Asthma control test score below
  • * Caregiver able operate a mobile application
  • * Has access high-speed wireless internet (WiFi) at home
  • * Able to read English
  • * Agreement to adhere to medical device use regimen throughout the study duration
  • * Known allergy to silicone, gold, or zinc
  • * Abnormal skin conditions on chest
  • * Sleep apnea diagnosis

Ages Eligible for Study

3 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Irina Dralyuk,

Irina Dralyuk, MD, PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

2026-02